Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Lanzhu, Yue"'
Autor:
Limin Xing, Yihao Wang, Hui Liu, Shan Gao, Qing Shao, Lanzhu Yue, Zhaoyun Liu, Huaquan Wang, Zonghong Shao, Rong Fu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chimeric antigen receptor T (CAR-T) cells show good efficacy in the treatment of relapsed and refractory B-cell tumors, such as acute B-cell leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL). The main toxicities of CAR-T include cytokine relea
Externí odkaz:
https://doaj.org/article/842add3fe68b482f80b2ad8142ae76db
Autor:
Qi Lv, Haiyue Niu, Lanzhu Yue, Jiaxi Liu, Liyan Yang, Chunyan Liu, Huijuan Jiang, Shuwen Dong, Zonghong Shao, Limin Xing, Huaquan Wang
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundFerroptosis is a form of iron-dependent non-apoptotic cell death, with characteristics of loss of the activity of the lipid repair enzyme, glutathione (GSH) peroxidase 4 (GPX4), and accumulation of lethal reactive lipid oxygen species. The
Externí odkaz:
https://doaj.org/article/7b65c64b32304e099a253e1da00ee66b
Autor:
Ying Han, Lanzhu Yue, Max Wei, Xiubao Ren, Zonghong Shao, Ling Zhang, Ross L Levine, Pearlie K Epling-Burnette
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0166014 (2017)
Myelofibrosis is an indicator of poor prognosis in myeloproliferative neoplasms (MPNs), but the precise mechanism(s) contributing to extracellular matrix remodeling and collagen deposition in the bone marrow (BM) niche remains unanswered. In this stu
Externí odkaz:
https://doaj.org/article/c6123e826fd9460c8151dd163fa340b6
Autor:
Jing Li, Lanzhu Yue, Huaquan Wang, Chunyan Liu, Hui Liu, Jinglian Tao, Weiwei Qi, Yihao Wang, Wei Zhang, Rong Fu, Zonghong Shao
Publikováno v:
Journal of Immunology Research, Vol 2016 (2016)
Th17 cells are a newly found subset of distinct CD4+ Th effector cells’ family and are found to play an important role in cancers. Myelodysplastic syndromes (MDS) are a common malignant hematological disease. Here, we showed that both the percentag
Externí odkaz:
https://doaj.org/article/d2786c78b62d4a87a92d9222da34260d
Autor:
Huaquan Wang, Ningbo Cui, Chunyan Liu, Lifang Guo, Liyan Yang, Lanzhu Yue, Huijuan Jiang, Zonghong Shao
Publikováno v:
Oncotarget
// Huijuan Jiang 1, * , Ningbo Cui 1, * , Liyan Yang 1, * , Chunyan Liu 1 , Lanzhu Yue 1 , Lifang Guo 1 , Huaquan Wang 1 and Zonghong Shao 1 1 Department of Hematology, General Hospital, Tianjin Medical University, Tianjin 300052, China * These autho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245bcf038aabacb5d1ac6f141c63d8e1
https://doi.org/10.18632/oncotarget.21548
https://doi.org/10.18632/oncotarget.21548
Autor:
Xue-Zhong Yu, John M. Koomen, Nicholas J. Lawrence, Mario R. Fernandez, William E. Goodheart, John L. Cleveland, Adam W. Mailloux, Ying Han, Anjali M. Rajadhyaksha, Muhammad Ayaz, Sang Y Yun, Matthew Beatty, Afua A. Akuffo, Jianing Fu, Timothy J. Garrett, Lancia Darville, Pearlie K. Epling-Burnette, Robert J. Gillies, Lanzhu Yue, Chunying Yang, Shiun Chang, Kun Jiang, Aileen Y. Alontaga, Rebecca S Hesterberg, Julia M.R. Billington, Jessica M. McDaniel, Jane L. Messina, Harshani R. Lawrence, Christelle M. Colin, Xiubao Ren, Shonagh Russell
Publikováno v:
Blood
Immunomodulatory drugs, such as thalidomide and related compounds, potentiate T-cell effector functions. Cereblon (CRBN), a substrate receptor of the DDB1-cullin-RING E3 ubiquitin ligase complex, is the only molecular target for this drug class, wher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c96ac76a73d87efec574673d4fa6f062
https://europepmc.org/articles/PMC7426646/
https://europepmc.org/articles/PMC7426646/
Autor:
Shuwen Dong, Lanzhu Yue, Huaquan Wang, Qi Lv, Chunyan Liu, Zonghong Shao, Haiyue Niu, Huijuan Jiang, Jiaxi Liu, Limin Xing, Liyan Yang
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Background Ferroptosis is a form of iron-dependent non-apoptotic cell death, with characteristics of loss of the activity of the lipid repair enzyme, glutathione (GSH) peroxidase 4 (GPX4), and accumulation of lethal reactive lipid oxygen species. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9fdfe622a1b73f2fa649814cd9fb6c8
https://pubmed.ncbi.nlm.nih.gov/32984038
https://pubmed.ncbi.nlm.nih.gov/32984038
Autor:
Chunyan Liu, Zonghong Shao, Haiyue Niu, Limin Xing, Huijuan Jiang, Jiaxi Liu, Liyan Yang, Lanzhu Yue, Huaquan Wang, Qi Lv
Publikováno v:
International journal of laboratory hematologyREFERENCES. 42(4)
Hemorrhage and infection are two main causes of death in patients with myelodysplastic syndromes (MDS), and it is becoming increasingly clear that platelet dysfunction can also affect the process of hemostasis and anti-infection. The aim of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5458564f924cde339e7f63eb4b801d19
https://pubmed.ncbi.nlm.nih.gov/32202052
https://pubmed.ncbi.nlm.nih.gov/32202052
Autor:
Ross L. Levine, Chiara Conti, Lanzhu Yue, Eva Sahakian, Nathan P. Horvat, Amit Verma, John Powers, Narmin E. Amin, Afua A. Akuffo, Kenneth L. Wright, C. Gary Marshall, Pui Yee Ng, Ling Zhang, Javier Pinilla-Ibarz, Xiaozhang Zheng, John M. Koomen, Julia M.R. Billington, Zonghong Shao, Matthew Beatty, Lancia Darville, Christelle M. Colin, Pearlie K. Epling-Burnette, Eduardo M. Sotomayor, Que T. Lambert-Showers, Jennifer Y. Lee, Matthew W. Martin, Gary W. Reuther, Cem Murdun, H. Leighton Grimes, William E. Goodheart, Vasundhara Sharma
Publikováno v:
Blood
Protein acetylation is an important contributor to cancer initiation. Histone deacetylase 6 (HDAC6) controls JAK2 translation and protein stability and has been implicated in JAK2-driven diseases best exemplified by myeloproliferative neoplasms (MPNs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634ceea44a77557b60fe813516a9e8b7
https://pubmed.ncbi.nlm.nih.gov/31750881
https://pubmed.ncbi.nlm.nih.gov/31750881
Autor:
Pearlie K. Burnette, Rebecca S Hesterberg, Vasundhara Sharma, Jennifer Y. Lee, Xiaozhang Zheng, Agni Christodoulidou, Lanzhu Yue, Kenneth L. Wright, Aileen Y. Alontaga, William E. Goodheart, Matthew W. Martin
Publikováno v:
Cancer Research. 78:LB-249
Therapeutic molecules targeting the activity of histone deacetylases (HDACs) are currently under investigation for the treatment of several malignancies. There are currently eighteen human HDACs and while histone deacetylation is associated with tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f2ff4c8382840b3b213046a052db469
https://doi.org/10.1158/1538-7445.am2018-lb-249
https://doi.org/10.1158/1538-7445.am2018-lb-249